# AerSale Corp: financial statements, quarterly

ASLE · Nasdaq · CIK 1754170 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/asle.md) · [Financials](/companies/asle/financials.md) · [Filings](/companies/asle/filings.md) · [Insiders](/companies/asle/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/asle/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [92.5](/filings/0001558370-24-014953.md) | [94.4 d](/filings/0001104659-26-025574.md) | [90.5](/filings/0001558370-25-006970.md) | [77.1](/filings/0001558370-25-010799.md) | [82.7](/filings/0001104659-25-108481.md) | [94.7 d](/filings/0001104659-26-025574.md) | [65.8](/filings/0001104659-26-057983.md) | [107](/filings/0001104659-26-092710.md) | [71.2](/filings/0001104659-25-108481.md) | [90.9 d](/filings/0001104659-26-025574.md) | [70.6](/filings/0001104659-26-057983.md) | [70.9](/filings/0001104659-26-092710.md) |
| Cost of revenue | $m | [69.0](/filings/0001558370-24-014953.md) | [70.0 d](/filings/0001104659-26-025574.md) | [61.7](/filings/0001558370-25-006970.md) | [55.4](/filings/0001558370-25-010799.md) | [59.0](/filings/0001104659-25-108481.md) | [65.0 d](/filings/0001104659-26-025574.md) | [47.8](/filings/0001104659-26-057983.md) | [72.0](/filings/0001104659-26-092710.md) | [49.7](/filings/0001104659-25-108481.md) | [60.0 d](/filings/0001104659-26-025574.md) | [51.7](/filings/0001104659-26-057983.md) | [54.7](/filings/0001104659-26-092710.md) |
| Gross profit | $m | [23.5](/filings/0001558370-24-014953.md) | [24.4 d](/filings/0001104659-26-025574.md) | [28.8](/filings/0001558370-25-006970.md) | [21.7](/filings/0001558370-25-010799.md) | [23.7](/filings/0001104659-25-108481.md) | [29.7 d](/filings/0001104659-26-025574.md) | [18.0](/filings/0001104659-26-057983.md) | [35.3](/filings/0001104659-26-092710.md) | [21.5](/filings/0001104659-25-108481.md) | [31.0 d](/filings/0001104659-26-025574.md) | [18.9](/filings/0001104659-26-057983.md) | [16.3](/filings/0001104659-26-092710.md) |
| Selling, general and administrative | $m | [25.4](/filings/0001558370-24-014953.md) | [25.5 d](/filings/0001104659-26-025574.md) | [24.1](/filings/0001558370-25-006970.md) | [23.6](/filings/0001558370-25-010799.md) | [21.7](/filings/0001104659-25-108481.md) | [24.8 d](/filings/0001104659-26-025574.md) | [24.6](/filings/0001104659-26-057983.md) | [22.8](/filings/0001104659-26-092710.md) | [18.6](/filings/0001104659-25-108481.md) | [23.9 d](/filings/0001104659-26-025574.md) | [22.2](/filings/0001104659-26-057983.md) | [21.0](/filings/0001104659-26-092710.md) |
| Operating income | $m | [(1.9)](/filings/0001558370-24-014953.md) | [(1.1) d](/filings/0001104659-26-025574.md) | [4.7](/filings/0001558370-25-006970.md) | [(1.9)](/filings/0001558370-25-010799.md) | [2.0](/filings/0001104659-25-108481.md) | [4.9 d](/filings/0001104659-26-025574.md) | [(6.6)](/filings/0001104659-26-057983.md) | [12.5](/filings/0001104659-26-092710.md) | [2.9](/filings/0001104659-25-108481.md) | [7.1 d](/filings/0001104659-26-025574.md) | [(3.3)](/filings/0001104659-26-057983.md) | [(4.8)](/filings/0001104659-26-092710.md) |
| Income tax | $m | [(2.0)](/filings/0001558370-24-014953.md) | [2.1 d](/filings/0001104659-26-025574.md) | [(0.4)](/filings/0001558370-25-006970.md) | [0.5](/filings/0001558370-25-010799.md) | [0.1](/filings/0001104659-25-108481.md) | [1.8 d](/filings/0001104659-26-025574.md) | [(0.7)](/filings/0001104659-26-057983.md) | [1.8](/filings/0001104659-26-092710.md) | [0.7](/filings/0001104659-25-108481.md) | [0.2 d](/filings/0001104659-26-025574.md) | [(1.0)](/filings/0001104659-26-057983.md) | [(1.6)](/filings/0001104659-26-092710.md) |
| Net income | $m | [(0.1)](/filings/0001558370-24-014953.md) | [(2.7) d](/filings/0001104659-26-025574.md) | [6.3](/filings/0001104659-25-108481.md) | [(3.6)](/filings/0001104659-25-108481.md) | [0.5](/filings/0001104659-25-108481.md) | [2.7 d](/filings/0001104659-26-025574.md) | [(5.3)](/filings/0001104659-26-092710.md) | [8.6](/filings/0001104659-26-092710.md) | [(0.1)](/filings/0001104659-25-108481.md) | [5.4 d](/filings/0001104659-26-025574.md) | [(3.5)](/filings/0001104659-26-092710.md) | [(5.6)](/filings/0001104659-26-092710.md) |
| Diluted EPS | $ per share | [0.00](/filings/0001558370-24-014953.md) | not reported | [0.12](/filings/0001558370-25-006970.md) | [(0.07)](/filings/0001558370-25-010799.md) | [0.01](/filings/0001104659-25-108481.md) | not reported | [(0.10)](/filings/0001104659-26-057983.md) | [0.18](/filings/0001104659-26-092710.md) | [0.00](/filings/0001104659-25-108481.md) | not reported | [(0.07)](/filings/0001104659-26-057983.md) | [(0.12)](/filings/0001104659-26-092710.md) |
| Basic EPS | $ per share | [0.00](/filings/0001558370-24-014953.md) | not reported | [0.12](/filings/0001558370-25-006970.md) | [(0.07)](/filings/0001558370-25-010799.md) | [0.01](/filings/0001104659-25-108481.md) | not reported | [(0.10)](/filings/0001104659-26-057983.md) | [0.18](/filings/0001104659-26-092710.md) | [0.00](/filings/0001104659-25-108481.md) | not reported | [(0.07)](/filings/0001104659-26-057983.md) | [(0.12)](/filings/0001104659-26-092710.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [3.2](/filings/0001558370-23-018321.md) | [5.9](/filings/0001558370-25-002624.md) | [2.6](/filings/0001558370-24-007648.md) | [4.3](/filings/0001558370-24-011383.md) | [9.8](/filings/0001558370-24-014953.md) | [4.7](/filings/0001104659-26-025574.md) | [4.7](/filings/0001558370-25-006970.md) | [5.7](/filings/0001558370-25-010799.md) | [5.3](/filings/0001104659-25-108481.md) | [4.4](/filings/0001104659-26-092710.md) | [2.1](/filings/0001104659-26-057983.md) | [2.2](/filings/0001104659-26-092710.md) |
| Current assets | $m | [286](/filings/0001558370-23-018321.md) | [265](/filings/0001558370-25-002624.md) | [288](/filings/0001558370-24-007648.md) | [296](/filings/0001558370-24-011383.md) | [340](/filings/0001558370-24-014953.md) | [284](/filings/0001104659-26-025574.md) | [329](/filings/0001558370-25-006970.md) | [327](/filings/0001558370-25-010799.md) | [323](/filings/0001104659-25-108481.md) | [269](/filings/0001104659-26-092710.md) | [282](/filings/0001104659-26-057983.md) | [296](/filings/0001104659-26-092710.md) |
| Total assets | $m | [554](/filings/0001558370-23-018321.md) | [554](/filings/0001558370-25-002624.md) | [572](/filings/0001558370-24-007648.md) | [599](/filings/0001558370-24-011383.md) | [601](/filings/0001558370-24-014953.md) | [605](/filings/0001104659-26-025574.md) | [646](/filings/0001558370-25-006970.md) | [647](/filings/0001558370-25-010799.md) | [646](/filings/0001104659-25-108481.md) | [640](/filings/0001104659-26-092710.md) | [668](/filings/0001104659-26-057983.md) | [687](/filings/0001104659-26-092710.md) |
| Current liabilities | $m | [56.9](/filings/0001558370-23-018321.md) | [45.7](/filings/0001558370-25-002624.md) | [40.2](/filings/0001558370-24-007648.md) | [43.0](/filings/0001558370-24-011383.md) | [47.1](/filings/0001558370-24-014953.md) | [75.0](/filings/0001104659-26-025574.md) | [72.6](/filings/0001558370-25-006970.md) | [84.4](/filings/0001558370-25-010799.md) | [73.2](/filings/0001104659-25-108481.md) | [72.4](/filings/0001104659-26-092710.md) | [75.3](/filings/0001104659-26-057983.md) | [90.7](/filings/0001104659-26-092710.md) |
| Total liabilities | $m | [103](/filings/0001558370-23-018321.md) | [109](/filings/0001558370-25-002624.md) | [120](/filings/0001558370-24-007648.md) | [149](/filings/0001558370-24-011383.md) | [150](/filings/0001558370-24-014953.md) | [149](/filings/0001104659-26-025574.md) | [240](/filings/0001558370-25-006970.md) | [231](/filings/0001558370-25-010799.md) | [229](/filings/0001104659-25-108481.md) | [216](/filings/0001104659-26-092710.md) | [245](/filings/0001104659-26-057983.md) | [268](/filings/0001104659-26-092710.md) |
| Long-term debt | $m | [7.9](/filings/0001558370-23-018321.md) | [36.3](/filings/0001558370-25-002624.md) | [55.5](/filings/0001558370-24-007648.md) | [81.5](/filings/0001558370-24-011383.md) | [78.9](/filings/0001558370-24-014953.md) | [40.4](/filings/0001104659-26-025574.md) | [134](/filings/0001558370-25-006970.md) | [115](/filings/0001558370-25-010799.md) | [125](/filings/0001104659-25-108481.md) | [111](/filings/0001104659-26-092710.md) | [139](/filings/0001104659-26-057983.md) | [147](/filings/0001104659-26-092710.md) |
| Current portion of debt | $m | [0.6](/filings/0001558370-23-018321.md) | [1.3](/filings/0001558370-25-002624.md) | [1.0](/filings/0001558370-24-007648.md) | [0.1](/filings/0001558370-24-011383.md) | [0.2](/filings/0001558370-24-014953.md) | [0.6](/filings/0001104659-26-025574.md) | [0.8](/filings/0001558370-25-006970.md) | [0.8](/filings/0001558370-25-010799.md) | [1.0](/filings/0001104659-25-108481.md) | [1.0](/filings/0001104659-26-092710.md) | [1.0](/filings/0001104659-26-057983.md) | [1.0](/filings/0001104659-26-092710.md) |
| Shareholders' equity | $m | [451](/filings/0001558370-24-014953.md) | [445](/filings/0001104659-26-025574.md) | [452](/filings/0001104659-25-108481.md) | [450](/filings/0001104659-25-108481.md) | [452](/filings/0001104659-25-108481.md) | [456](/filings/0001104659-26-092710.md) | [406](/filings/0001104659-26-092710.md) | [416](/filings/0001104659-26-092710.md) | [417](/filings/0001104659-25-108481.md) | [424](/filings/0001104659-26-092710.md) | [423](/filings/0001104659-26-092710.md) | [419](/filings/0001104659-26-092710.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt, us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(38.9) d](/filings/0001558370-24-014953.md) | [(6.1) d](/filings/0001104659-26-025574.md) | [(21.5)](/filings/0001558370-25-006970.md) | [(15.3) d](/filings/0001558370-25-010799.md) | [10.4 d](/filings/0001104659-25-108481.md) | [37.5 d](/filings/0001104659-26-025574.md) | [(45.2)](/filings/0001104659-26-057983.md) | [19.8 d](/filings/0001104659-26-092710.md) | [(8.9) d](/filings/0001104659-25-108481.md) | [11.4 d](/filings/0001104659-26-025574.md) | [(26.7)](/filings/0001104659-26-057983.md) | [(6.8) d](/filings/0001104659-26-092710.md) |
| Capital expenditure | $m | [3.0 d](/filings/0001558370-24-014953.md) | [3.6 d](/filings/0001104659-26-025574.md) | [3.6](/filings/0001558370-25-006970.md) | [3.6 d](/filings/0001558370-25-010799.md) | [1.6 d](/filings/0001104659-25-108481.md) | [5.3 d](/filings/0001104659-26-025574.md) | [2.4](/filings/0001104659-26-057983.md) | [1.2 d](/filings/0001104659-26-092710.md) | [0.9 d](/filings/0001104659-25-108481.md) | [1.6 d](/filings/0001104659-26-025574.md) | [1.1](/filings/0001104659-26-057983.md) | [0.7 d](/filings/0001104659-26-092710.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [51.7](/filings/0001558370-23-018321.md) | [53.0](/filings/0001558370-24-007648.md) | [51.4](/filings/0001558370-24-011383.md) | [51.3](/filings/0001558370-24-014953.md) | [53.2](/filings/0001558370-25-006970.md) | [53.0](/filings/0001558370-25-010799.md) | [53.4](/filings/0001104659-25-108481.md) | [52.3](/filings/0001104659-26-057983.md) | [47.1](/filings/0001104659-26-092710.md) | [47.2](/filings/0001104659-25-108481.md) | [47.2](/filings/0001104659-26-057983.md) | [47.3](/filings/0001104659-26-092710.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 52,990,947 at 2034-03-05, from the cover of the [10-K/A filed 2024-03-27](/filings/0001558370-24-004010.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.